Since our establishment, we have worked with a number of industry-leading clients, working to provide an efficient, successful service that delivers the best possible results for you. Some of these clients include:
About Us
Welcome to
Odelle Technology
Odelle Technology is an established consultancy dedicated to helping MedTech, Biotech and Diagnostics businesses navigate the public and private healthcare sectors across Europe to secure the adoption and reimbursement of their technology. Our professional team has over 95 years of combined experience in the healthcare sector, using their knowledge and skills to deliver an exceptional service to clients in the United Kingdom and throughout Europe.
We pride ourselves on our prosperous track record, having successfully submitted 112 Health Technology Assessments and the successful adoption of 66 National Guidelines in the last 15 years. We have supported a large number of clients through the development and launch of their technology, helping them gain access to local and national markets and securing National Standards of Care for their technology.

With projects covering a wide range of innovations you can trust us to do exactly what you need.
We speak the language. We know the systems. We have the experience and successes to prove it.
Our achievements
0
Submitted 119 health technology assessments resulting in policy initiatives and adoption
0
Introduced 79 national guidelines
our submissions include
- CNEDiMTS - 27 successful submissions
- Autorisation Temporaire d’Utilisation (ATU) -18 successful submissions
- Comite 'Economique des Produits de Sante´ (CEPS) - 28 successful submissions
- IQWiG - 17 successful submissions
- Gemeinsamer Bundesausschuss - 15 successful projects
- Accelerated Access Collaborate NHS Successful application in 2022 full commissioning
- NHS England’s Cancer Drugs Fund 2018 and 2021 National adoption
- 37 successful Medical Technologies Guidance (MTG) NICE
- 9 Guidelines recommendations with Denmark Treatment Council (Behandlingsråd)
- Three Patient pathway changes with Innovation Committee at the Federal Joint Committee (G-BA)
- Five new technologies Article 51 of the Social Security Financing Act in France
+44 (0) 7804 623 339
Unit 1-2
Field View Business Park
Bicester
UNITED KINGDOM
OX27 7SG
15 Rue de President Roosevelt
Pons
FRANCE
17800